Alexandra Livingstone

Affiliations: 
University of Rochester, Rochester, NY 
Area:
Immunology, Microbiology Biology
Google:
"Alexandra Livingstone"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang AZ, Mashimo BL, Schaettler MO, et al. (2024) Glioblastoma-infiltrating CD8+ T cells are predominantly a clonally expanded GZMK+ effector population. Cancer Discovery
Khan SM, Desai R, Coxon A, et al. (2022) Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. Journal For Immunotherapy of Cancer. 10
Prizant H, Patil N, Negatu S, et al. (2021) CXCL10 peripheral activation niches couple preferred sites of Th1 entry with optimal APC encounter. Cell Reports. 36: 109523
Wonderlich J, Shearer G, Livingstone A, et al. (2018) Induction and Measurement of Cytotoxic T Lymphocyte Activity. Current Protocols in Immunology. 120: 3.11.1-3.11.29
Rebhahn JA, Deng N, Sharma G, et al. (2014) An animated landscape representation of CD4+ T-cell differentiation, variability, and plasticity: insights into the behavior of populations versus cells. European Journal of Immunology. 44: 2216-29
Wu H, Kumar A, Miao H, et al. (2011) Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors. Journal of Immunology (Baltimore, Md. : 1950). 187: 4474-82
Ontiveros F, Wilson EB, Livingstone AM. (2011) Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help. Immunology. 132: 549-58
Livingstone AM, Wilson EB, Ontiveros F, et al. (2009) Unravelling the mechanisms of help for CD8+ T cell responses. Immunologic Research. 45: 209-17
Hilchey SP, Hyrien O, Mosmann TR, et al. (2009) Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab. Blood. 113: 3809-12
Wilson EB, Livingstone AM. (2008) Cutting edge: CD4+ T cell-derived IL-2 is essential for help-dependent primary CD8+ T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 181: 7445-8
See more...